Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPITUBE-HEART
2021-001965-19Phase 3Completed
- Sponsor
- CHU de Nantes
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of norepinephrine in cardiac disease, sponsored by CHU de Nantes. Started Jun 2021; status: completed.
02
Drugs
norepinephrine
03
Conditions
cardiac disease
Beyond the preview
Go deeper on 2021-001965-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001965-19.